Home > Insider Trading > Filing (0001209191-22-062645)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-11-01	31	$2.53	25,006	No	4	P	Direct
Common Stock	Acquisiton	2022-11-02	31	$2.54	25,037	No	4	P	Direct
Common Stock	Acquisiton	2022-11-03	31	$2.44	25,068	No	4	P	Direct
Common Stock	Acquisiton	2022-11-04	31	$2.42	25,099	No	4	P	Direct
Common Stock	Acquisiton	2022-11-07	31	$2.45	25,130	No	4	P	Direct
Common Stock	Acquisiton	2022-11-08	31	$2.42	25,161	No	4	P	Direct
Common Stock	Acquisiton	2022-11-09	31	$2.37	25,192	No	4	P	Direct
Common Stock	Acquisiton	2022-11-10	31	$2.37	25,223	No	4	P	Direct
Common Stock	Acquisiton	2022-11-11	31	$2.32	25,254	No	4	P	Direct
Common Stock	Acquisiton	2022-11-14	31	$2.32	25,285	No	4	P	Direct
Common Stock	Acquisiton	2022-11-15	31	$2.35	25,316	No	4	P	Direct
Common Stock	Acquisiton	2022-11-16	31	$2.31	25,347	No	4	P	Direct
Common Stock	Acquisiton	2022-11-17	31	$2.29	25,378	No	4	P	Direct
Common Stock	Acquisiton	2022-11-18	31	$2.27	25,409	No	4	P	Direct
Common Stock	Acquisiton	2022-11-21	31	$2.38	25,440	No	4	P	Direct
Common Stock	Acquisiton	2022-11-22	31	$2.37	25,471	No	4	P	Direct
Common Stock	Acquisiton	2022-11-23	31	$2.29	25,502	No	4	P	Direct
Common Stock	Acquisiton	2022-11-25	31	$2.31	25,533	No	4	P	Direct
Common Stock	Acquisiton	2022-11-28	31	$2.37	25,564	No	4	P	Direct
Common Stock	Acquisiton	2022-11-29	31	$2.34	25,595	No	4	P	Direct
Common Stock	Acquisiton	2022-11-30	31	$2.32	25,626	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.